Management of Persistent Hypernatremia in Intracranial Hemorrhage

Primary Recommendation

In patients with intracranial hemorrhage and persistent hypernatremia, the American College of Anaesthesiologists recommends discontinuing or reducing hypertonic saline infusions when serum sodium exceeds 155 mmol/L, as prolonged hypernatremia does not improve outcomes and increases risk of complications, while the acute ICP-lowering benefits have already been achieved 1, 2, 3

The therapeutic target range for serum sodium when using hypertonic saline for ICP control is 145-155 mmol/L, according to the Stroke guidelines 4, 5
The upper safety limit for sodium levels is 155-160 mmol/L to prevent complications, as recommended by the Anaesthesia guidelines 1, 3
Sustained sodium >170 mEq/L for >72 hours significantly increases risk of thrombocytopenia, renal failure, neutropenia, and acute respiratory distress syndrome, according to the Praxis Medical Insights guidelines 3

The Anaesthesia guidelines recommend not re-administering hypertonic saline boluses until serum sodium is <155 mmol/L 1, 2, 3
If on continuous 3% hypertonic saline infusion, the Praxis Medical Insights guidelines recommend reducing the rate or discontinuing entirely based on current sodium level 3
The ICP-lowering effect of hypertonic saline lasts only 2-4 hours after bolus administration, so continued hypernatremia provides no additional benefit, according to the Praxis Medical Insights guidelines 3

The Stroke guidelines recommend considering mannitol as an alternative for acute ICP elevations, though hypertonic saline is generally more effective at equiosmolar doses 4, 3, 5
Typical mannitol dosing is 0.25-1 g/kg IV bolus over 15-20 minutes, according to the Stroke guidelines 4
The Praxis Medical Insights guidelines recommend not using mannitol and hypertonic saline simultaneously 5
Elevating the head of bed 20-30 degrees can assist venous drainage and reduce ICP, as recommended by the Stroke guidelines 4, 3

Despite hypertonic saline's effectiveness in reducing ICP, there is no evidence it improves neurological outcomes (Grade B) or survival (Grade A) in patients with raised intracranial pressure, according to the Anaesthesia guidelines 1, 2, 3
The 2018 guidelines for severe traumatic brain injury explicitly recommend against using prolonged hypernatremia to control ICP (Grade 2-, Strong Agreement), as stated in the Anaesthesia guidelines 1, 2

The Praxis Medical Insights guidelines recommend monitoring serum sodium every 4-6 hours during the correction phase 5
The Praxis Medical Insights guidelines also recommend monitoring serum osmolality daily during the correction phase 5
The Stroke guidelines recommend performing neurological examinations every 2-4 hours during the correction phase 4
The Praxis Medical Insights guidelines recommend monitoring ICP if a catheter is in place during the correction phase 5

In brain injury patients with hypernatremia, discontinuing or reducing hypertonic saline infusions when sodium exceeds 155 mmol/L and switching to 0.9% normal saline for maintenance fluids is recommended, as prolonged hypernatremia does not improve outcomes and increases complications, according to the 2018 guidelines (Grade 2-, Strong Agreement) 6
The relationship between serum sodium and intracranial pressure (ICP) is weak, and theoretical benefits of hypertonic saline require an intact blood-brain barrier, which is often disrupted in brain injury 6
Rapid brain cell volume regulation limits the effectiveness of prolonged hyperosmolarity, creating a risk of "rebound" ICP during correction, and hypernatremia-associated hyperchloremia may impair renal function 6

Switching to 0.9% normal saline for maintenance fluids is recommended, as it is the only commonly available isotonic crystalloid appropriate for brain injury (Strong recommendation, moderate quality evidence) 7
Avoiding hypotonic solutions, such as Ringer's lactate or Ringer's acetate, is recommended, as they are hypotonic when real osmolality is measured and will increase brain water (Strong recommendation, moderate quality evidence) 7
Never using albumin in traumatic brain injury patients is recommended, as it increases mortality (Strong recommendation, moderate quality evidence) 7